Fig. 1From: Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)Antiretroviral therapy drug regimens in patients initiating darunavir/cobicistat (DRV/c). 3TC: lamivudine; ABC: abacavir; DRV/c: darunavir/cobicistat; DTG: dolutegravir; FTC: emtricitabine; RAL: raltegravir; TDF: tenofovirBack to article page